Tumor metabolic and secondary lymphoid organ metabolic markers on 18F-fludeoxyglucose positron emission tomography predict prognosis of immune checkpoint inhibitors in advanced lung cancer

BACKGROUND: The purpose of this study was to investigate the predictive value of tumor metabolic parameters in combination with secondary lymphoid metabolic parameters on positron emission tomography (PET)/computed tomography (CT) for immune checkpoint inhibitor (ICI) prognosis in advanced lung canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Peng, Bai, Menglin, Liu, Jie, Yu, Jinming, Meng, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634068/
https://www.ncbi.nlm.nih.gov/pubmed/36341372
http://dx.doi.org/10.3389/fimmu.2022.1004351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634068/
https://www.ncbi.nlm.nih.gov/pubmed/36341372
http://dx.doi.org/10.3389/fimmu.2022.1004351

Ejemplares similares